COVID-19 as an acute inflammatory disease

RH Manjili, M Zarei, M Habibi… - The journal of immunology, 2020 - journals.aai.org
acute respiratory syndrome (SARS) coronavirus (SARSCoV)-2 and named the disease as the
2019 novel coronavirus disease (COVID-19… syndrome (MERS) coronavirus (MERS-CoV) (1…

[HTML][HTML] Autoimmune and inflammatory diseases following COVID-19

C Galeotti, J Bayry - Nature Reviews Rheumatology, 2020 - nature.com
… that coronavirus disease 2019 (COVID-19), a pandemic respiratory infectious disease caused
by severe acute … Kawasaki disease and Kawasaki disease associated with COVID-19 (KD-…

COVID-19: inflammatory profile

Y Wang, S Perlman - Annual review of medicine, 2022 - annualreviews.org
… elevated in patients with severe disease and correlated with COVID-19 progression (15). …
inflammatory disease, TNF inhibitors are predicted to be useful in dampening COVID-19

Characterization of the inflammatory response to severe COVID-19 illness

OJ McElvaney, NL McEvoy, OF McElvaney… - American journal of …, 2020 - atsjournals.org
COVID-19 cytokinemia and the inflammatory phenotype of the critically unwell patient with
COVID-19 … presence of immunometabolic reprogramming in patients with severe COVID-19. …

Orbital inflammatory disease associated with COVID-19 infection

T Eleiwa, SN Abdelrahman, RH ElSheikh… - Journal of American …, 2021 - Elsevier
… ophthalmic manifestation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2…
patients with corona virus disease 2019 (COVID-19). Orbital inflammatory disease has been …

[PDF][PDF] Autoimmune and chronic inflammatory disease patients with COVID19

RC Ungaro, M Agrawal, S Park, R Hirten… - ACR Open …, 2021 - Wiley Online Library
… medications with severe COVID-19 among … severe COVID-19 (Table 4). However, systemic
corticosteroid use was significantly associated with an increased risk of severe COVID-19 (…

COVID-19: immunopathogenesis and Immunotherapeutics

L Yang, S Liu, J Liu, Z Zhang, X Wan… - Signal transduction and …, 2020 - nature.com
… These observations indicate that B cell activation and proliferation in patients with COVID-19,
especially in severe cases, is correlated with poor outcome, which is similar to our study …

COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses

F Fagni, D Simon, K Tascilar, V Schoenau… - The Lancet …, 2021 - thelancet.com
… data on the risk for SARS-CoV-2 infection and severe COVID-19 in patients with immune-mediated
inflammatory diseases of the joints, skin, and gut, as well as systemic diseases. …

Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients

FAI2R/SFR/SNFMI/SOFREMIP/CRI/IMIDIATE … - … Rheumatic Diseases, 2021 - ard.bmj.com
diseases, their comorbidities and the use of immunotherapies may affect progression to severe
COVID-19 … iRMD and COVID-19, was to investigate the frequency of severe infection and …

Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective

C Lee, WJ Choi - Archives of pharmacal research, 2021 - Springer
… A new beta coronavirus strain called severe acute respiratory syndrome … many chronic
inflammatory diseases, it may further exacerbate inflammatory conditions of COVID-19 patients by …